These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Evaluation of ACTH and corticosteroid therapy in multiple sclerosis]. Hamel-Puskarić N; Arko K; Dupelj M; Novak Z; Barac B; Czukor M Neuropsihijatrija; 1969; 17(1):51-70. PubMed ID: 4191305 [No Abstract] [Full Text] [Related]
23. Uhthoff's symptom in optic neuritis: relationship to magnetic resonance imaging and development of multiple sclerosis. Scholl GB; Song HS; Wray SH Ann Neurol; 1991 Aug; 30(2):180-4. PubMed ID: 1654765 [TBL] [Abstract][Full Text] [Related]
24. [Paroxysmal attacks of dysarthria and ataxia in multiple sclerosis]. Zavalishin IA; Nevskaia OM; Niiazbekova AS Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(11):1645-9. PubMed ID: 726759 [TBL] [Abstract][Full Text] [Related]
25. Optic neuritis and its relationship to disseminated sclerosis. Landy PJ; Ohlrich GD Proc Aust Assoc Neurol; 1970; 7():67-70. PubMed ID: 4328431 [No Abstract] [Full Text] [Related]
26. Age at disability milestones in multiple sclerosis. Confavreux C; Vukusic S Brain; 2006 Mar; 129(Pt 3):595-605. PubMed ID: 16415309 [TBL] [Abstract][Full Text] [Related]
27. Methyl mercury poisoning in Iraq. A neurological study. Rustam H; Hamdi T Brain; 1974 Sep; 97(3):500-10. PubMed ID: 4425451 [No Abstract] [Full Text] [Related]
28. [Characteristics of the ophthalmological disorders in the initial stages of disseminated sclerosis in young and older patients]. Matiushko NG Vrach Delo; 1988 Jul; (7):86-7. PubMed ID: 3188482 [No Abstract] [Full Text] [Related]
29. Paroxysmal signs and symptoms in multiple sclerosis. Miley CE; Forster FM Neurology; 1974 May; 24(5):458-61. PubMed ID: 4363817 [No Abstract] [Full Text] [Related]
33. [Clinical study of delayed onset of multiple sclerosis]. Giovannucci M G Psichiatr Neuropatol; 1968; 96(4):751-78. PubMed ID: 5738035 [No Abstract] [Full Text] [Related]
34. [Primary progressive forms of multiple sclerosis: application of the new diagnostic criteria in French]. De Seze J; Mackowiak A; Stojkovic T; Ferriby D; Hautecoeur P; Vermersch P Rev Neurol (Paris); 2002 Mar; 158(3):341-5. PubMed ID: 11976594 [TBL] [Abstract][Full Text] [Related]
35. [Experience with the therapy of multiple sclerosis using ACTH]. Carella A; Lamberti P Acta Neurol (Napoli); 1969; 24(6):836-51. PubMed ID: 4314191 [No Abstract] [Full Text] [Related]
36. Changes in serum immunoglobulin concentrations in patients with multiple sclerosis during the treatment with ACTH. Maciejek Z; Rebeś Z; Kubasiewicz B Arch Immunol Ther Exp (Warsz); 1981; 29(2):141-4. PubMed ID: 6272663 [TBL] [Abstract][Full Text] [Related]
37. Movement disorders in multiple sclerosis. Tranchant C; Bhatia KP; Marsden CD Mov Disord; 1995 Jul; 10(4):418-23. PubMed ID: 7565820 [TBL] [Abstract][Full Text] [Related]
38. [Effect of pyrogenal on dynamics of reflex-motor disorders in patients with diffuse sclerosis]. Tiazhkorob AM; Il'iash TI; Zhovnir IK Vrach Delo; 1988 Nov; (11):81-3. PubMed ID: 3238989 [No Abstract] [Full Text] [Related]
40. Comparison of the natural history and prognostic features of early onset and adult onset multiple sclerosis in Jordanian population. El-Salem K; Khader Y Clin Neurol Neurosurg; 2007 Jan; 109(1):32-7. PubMed ID: 16870328 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]